Abstract
GEJ and gastric ADC have a biologic resemblances, and therapy could be similar. Incidence esophageal ADC is increasing. Gastric ADC is decreasing, but its absolute number is increasing. EUS is still considered a controversial restaging tool (difficulties to distinguish residual primary tumor, radiation effects and fibrosis). Clinicians rely more on PET-CT or CT, and sometimes avoid EUS.This work compares the accuracy of EUS and PET-CT in restaging esophageal and gastric ADC.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
